InvestorsHub Logo
Followers 60
Posts 7391
Boards Moderated 0
Alias Born 10/20/2014

Re: None

Monday, 05/06/2024 7:30:30 PM

Monday, May 06, 2024 7:30:30 PM

Post# of 426061
Does anyone know if EU patent exclusivity could be extended any further to beyond
the current 2039? (I thought in the past I read that certain new trials / new indications
could add on time.) Given that there are so many possible further indications for
Vascepa I wonder how much (if any) additional exclusivity status time could be
earned?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News